FRAF vs NUW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FRAF presents a stark contradiction between aggressive growth and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($65.14) and Intrinsic Value ($139.83), the low health score suggests underlying balance sheet or operational instability. Strong YoY earnings growth of 68.2% and a low PEG ratio of 1.03 provide a bullish growth narrative, but the bearish technical trend (10/100) and poor F-Score warrant caution.
The asset exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. There is a massive valuation gap between the current price of $14.11 and the calculated intrinsic value of $3.50, suggesting the fund is trading at a significant premium. Furthermore, the dividend payout ratio of 116.40% is unsustainable, as the fund is distributing more than it earns. Combined with a 0/100 technical trend, the data suggests a high risk of price correction.
Compare Another Pair
Related Comparisons
FRAF vs NUW: Head-to-Head Comparison
This page compares Franklin Financial Services Corporation (FRAF) and Nuveen AMT-Free Municipal Value Fund (NUW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.